Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase
Year: 2014
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm500847m
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2086453520
